AstraZeneca Olaparib gets CDSCO Panel okay for BRCA mutated HER2 negative breast cancer Dr. Divya Colin23 July 2022 6:00 PM ISTNew Delhi: Based on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug...
Novartis Ruxolitinib Gets CDSCO Panel Okay for Acute and Chronic Graft Versus Host Disease Dr. Divya Colin22 July 2022 6:00 PM ISTNew Delhi: In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert...
Merck Keytruda fails in head and neck cancer trial Ruchika Sharma21 July 2022 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
CDSCO panel rejects Optimus Pharma Phase III CT protocol of Tofacitinib Ointment for androgenic alopecia Dr. Divya Colin20 July 2022 6:00 PM ISTNew Delhi: Citing that there is no scientific rationality data and supportive published literature, the Subject Expert Committee (SEC) functional...
Sanofi gets CDSCO Panel okay to study Dupilumab Dr. Divya Colin19 July 2022 6:00 PM ISTNew Delhi: Directing to include all Serious Adverse Events (SAEs) and adverse events (AEs) of test drug in the informed consent document, the Subject...
Mylan Gets CDSCO Panel Nod To Study COPD drug Revefenacin inhalation solution Dr. Divya Colin18 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug...
Akum Pharmaceutical gets CDSCO Nod to study GERD.FDC drug Dr. Divya Colin17 July 2022 11:15 AM ISTNew Delhi: Drug major, Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Cipla Gets CDSCO Panel Nod To Study Inhaled Itraconazole Dry Powder for inhalation Dr. Divya Colin16 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Include more govt sites: CDSCO Panel to Parexel on Clinical Trial of Guselkumab Dr. Divya Colin15 July 2022 6:00 PM ISTNew Delhi: Highlighting the need of including more number of government sites to have the sites geographically distributed in the country, the Subject...
CDSCO panel nod to Roche anti cancer drug Atezolizumab for metastatic triple negative breast cancer Dr. Divya Colin14 July 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug...
Drug Alert: CDSCO flags 26 formulations as not of standard quality Dr. Divya Colin13 July 2022 6:15 PM ISTNew Delhi: In the latest drug safety alert, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO) has flagged 26...
Sun versus Cipla: Madras HC refuses to stop Sun Pharma from using word 'Respules' Ruchika Sharma12 July 2022 12:13 PM ISTPassing interim orders, the judge said the evidence on record indicates prima facie that the word 'Respules' is used both by other manufacturers and...
